Alison E. McGonagle

617 total citations
11 papers, 492 citations indexed

About

Alison E. McGonagle is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Alison E. McGonagle has authored 11 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Alison E. McGonagle's work include Histone Deacetylase Inhibitors Research (4 papers), Epigenetics and DNA Methylation (4 papers) and PARP inhibition in cancer therapy (3 papers). Alison E. McGonagle is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Epigenetics and DNA Methylation (4 papers) and PARP inhibition in cancer therapy (3 papers). Alison E. McGonagle collaborates with scholars based in United Kingdom, Australia and France. Alison E. McGonagle's co-authors include Stephen P. Marsden, Allan M. Jordan, Daniel P. Mould, Daniel H. Wiseman, Emma L. Williams, Donald Ogilvie, Helen Small, Ian D. Waddell, Kate M. Smith and James R. Hitchin and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Organic Letters.

In The Last Decade

Alison E. McGonagle

11 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison E. McGonagle United Kingdom 9 329 181 125 42 34 11 492
Arkadii Vaisburg Austria 12 426 1.3× 143 0.8× 130 1.0× 24 0.6× 11 0.3× 26 536
Jeffrey Tredup United States 10 191 0.6× 109 0.6× 71 0.6× 64 1.5× 16 0.5× 17 360
Shaun Fillery United Kingdom 11 334 1.0× 236 1.3× 121 1.0× 23 0.5× 30 0.9× 17 569
Rachana Ohri United States 9 208 0.6× 167 0.9× 195 1.6× 47 1.1× 33 1.0× 11 479
Jérôme Cluzeau Canada 11 276 0.8× 155 0.9× 71 0.6× 44 1.0× 20 0.6× 19 400
Michael R. Michaelides United States 14 580 1.8× 298 1.6× 141 1.1× 13 0.3× 28 0.8× 15 751
David P. Kay United States 9 356 1.1× 226 1.2× 169 1.4× 26 0.6× 12 0.4× 12 608
Steffen Breitfelder Germany 6 226 0.7× 179 1.0× 52 0.4× 22 0.5× 14 0.4× 6 383
Feng‐Zhi Suo China 14 414 1.3× 132 0.7× 82 0.7× 12 0.3× 29 0.9× 19 554
Nobuyuki Fukazawa Japan 8 347 1.1× 119 0.7× 208 1.7× 25 0.6× 10 0.3× 14 525

Countries citing papers authored by Alison E. McGonagle

Since Specialization
Citations

This map shows the geographic impact of Alison E. McGonagle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison E. McGonagle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison E. McGonagle more than expected).

Fields of papers citing papers by Alison E. McGonagle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison E. McGonagle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison E. McGonagle. The network helps show where Alison E. McGonagle may publish in the future.

Co-authorship network of co-authors of Alison E. McGonagle

This figure shows the co-authorship network connecting the top 25 collaborators of Alison E. McGonagle. A scholar is included among the top collaborators of Alison E. McGonagle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison E. McGonagle. Alison E. McGonagle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Small, Helen, Kate M. Smith, Alison E. McGonagle, et al.. (2019). Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores – A cautionary disclosure. Bioorganic & Medicinal Chemistry Letters. 29(4). 560–562. 1 indexed citations
2.
Waszkowycz, Bohdan, Kate M. Smith, Alison E. McGonagle, et al.. (2018). Cell-Active Small Molecule Inhibitors of the DNA-Damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides. Journal of Medicinal Chemistry. 61(23). 10767–10792. 26 indexed citations
3.
Mould, Daniel P., Ulf Bremberg, Allan M. Jordan, et al.. (2017). Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1. Bioorganic & Medicinal Chemistry Letters. 27(14). 3190–3195. 13 indexed citations
4.
Mould, Daniel P., Ulf Bremberg, Allan M. Jordan, et al.. (2017). Development and evaluation of 4-(pyrrolidin-3-yl)benzonitrile derivatives as inhibitors of lysine specific demethylase 1. Bioorganic & Medicinal Chemistry Letters. 27(20). 4755–4759. 10 indexed citations
5.
Mould, Daniel P., Cristina Alli, Ulf Bremberg, et al.. (2017). Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1. Journal of Medicinal Chemistry. 60(19). 7984–7999. 41 indexed citations
6.
James, Dominic I., Kate M. Smith, Allan M. Jordan, et al.. (2016). First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib. ACS Chemical Biology. 11(11). 3179–3190. 94 indexed citations
7.
Mould, Daniel P., Alison E. McGonagle, Daniel H. Wiseman, Emma L. Williams, & Allan M. Jordan. (2014). Reversible Inhibitors of LSD1 as Therapeutic Agents in Acute Myeloid Leukemia: Clinical Significance and Progress to Date. Medicinal Research Reviews. 35(3). 586–618. 108 indexed citations
8.
James, Dominic I., Allan M. Jordan, Nicola Hamilton, et al.. (2014). Abstract 2745: Pharmacological characterisation of cell active inhibitors of Poly(ADP-ribose) glycohydrolase (PARG). Cancer Research. 74(19_Supplement). 2745–2745. 2 indexed citations
9.
Raoof, Ali, Paul Depledge, Niall M. Hamilton, et al.. (2013). Toxoflavins and Deazaflavins as the First Reported Selective Small Molecule Inhibitors of Tyrosyl-DNA Phosphodiesterase II. Journal of Medicinal Chemistry. 56(16). 6352–6370. 55 indexed citations
10.
McGonagle, Alison E. & G. Paul Savage. (2009). Free-Radical Polymerization and Ring-Expansion of a Cubane Acrylate: a Unique Low-Shrink Polymer. Australian Journal of Chemistry. 62(2). 145–149. 12 indexed citations
11.
Marsden, Stephen P., et al.. (2008). Catalytic aza-Wittig Cyclizations for Heteroaromatic Synthesis. Organic Letters. 10(12). 2589–2591. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arkadii Vaisburg Breakdown of academic impact, for papers by Jeffrey Tredup Breakdown of academic impact, for papers by Shaun Fillery Breakdown of academic impact, for papers by Rachana Ohri Breakdown of academic impact, for papers by Jérôme Cluzeau Breakdown of academic impact, for papers by Michael R. Michaelides Breakdown of academic impact, for papers by David P. Kay Breakdown of academic impact, for papers by Steffen Breitfelder Breakdown of academic impact, for papers by Feng‐Zhi Suo Breakdown of academic impact, for papers by Nobuyuki Fukazawa
Rankless by CCL
2026